Journal
NATURE
Volume 510, Issue 7503, Pages 129-133Publisher
NATURE PORTFOLIO
DOI: 10.1038/nature13389
Keywords
-
Categories
Funding
- EPSRC
- GSK
- University of Cambridge
- ERC
- EPSRC [EP/I00548X/1] Funding Source: UKRI
- Engineering and Physical Sciences Research Council [EP/I00548X/1] Funding Source: researchfish
Ask authors/readers for more resources
The development of new chemical transformations based on catalytic functionalization of unactivated C-H bonds has the potential to simplify the synthesis of complex molecules dramatically. Transition metal catalysis has emerged as a powerful tool with which to convert these unreactive bonds into carbon-carbon and carbon-heteroatom bonds(1-6), but the selective transformation of aliphatic C-H bonds is still a challenge. The most successful approaches involve a 'directing group', which positions the metal catalyst near a particular C-H bond, so that the C-H functionalization step occurs via cyclometallation(7). Most directed aliphatic C-H activation processes proceed through a five-membered-ring cyclometallated intermediate(8-10). Considering the number of new reactions that have arisen from such intermediates, it seems likely that identification of distinct cyclometallation pathways would lead to the development of other useful chemical transformations(11). Here we report a palladium-catalysed C-H bond activation mode that proceeds through a four-membered-ring cyclopalladation pathway. The chemistry described here leads to the selective transformation of a methyl group that is adjacent to an unprotected secondary amine into a synthetically versatile nitrogen heterocycle. The scope of this previously unknown bond disconnection is highlighted through the development of C-H amination and carbonylation processes, leading to the synthesis of aziridines and beta-lactams (respectively), and is suggestive of a generic C-H functionalization platform that could simplify the synthesis of aliphatic secondary amines, a class of small molecules that are particularly important features of many pharmaceutical agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available